Bayer Stock (BAYN.DE): Live Price Chart

[[ data.name ]]

[[ data.ticker ]]

[[ data.price ]] [[ data.change ]] ([[ data.changePercent ]]%)

Low: [[ data.low ]]

High: [[ data.high ]]

Sell
[[ data.bid ]] [[ data.spreadText ]] Buy
[[ data.ask ]]

TRADE NOW

About

History

Differences between Investing vs Trading

About

History

Differences between Investing vs Trading

Bayer AG is a German multinational pharmaceutical and life sciences company founded in 1863. It is headquartered in Leverkusen, where its main research and development facilities are located. Bayer went public in 1896. The company's largest shareholder is still the Fritz family with around 6% ownership.

The company's biggest event in recent years was the acquisition of Monsanto in 2018, making Bayer the world's largest supplier of herbicides and pesticides. Bayer is organized into three main business units: Pharmaceuticals, Consumer Health, and Crop Science. The company also has a materials science division which produces high-performance polymers.

Bayer is a member of the DAX, an index of the 40 largest German companies trading on the Frankfurt Stock Exchange. It is also a component stock of the EU Stocks 50 stock market index.

After hitting an all-time high in 2016, the stock took a sharp dip in early 2017 following the announcement of the Monsanto acquisition. However, shares have since recovered and are currently trading near their all-time high once again.

Overall, it seems like Bayer is a company with a bright future despite some recent challenges. With a strong portfolio of products and a history of innovation, Bayer is well positioned to continue growing in the years ahead.

One thing to keep an eye on is the ongoing litigation related to Roundup weed killer. Although Bayer has maintained its stance that Roundup is safe, the lawsuits have been a drag on the stock. If Bayer is able to put this litigation behind it, the stock could see even more upside in the years ahead.

Investing in Bayer stock means that you will own a part of the company. This can give you certain rights as a shareholder, such as the right to vote at shareholders' meetings or receive dividends (if the company pays them). However, investing also comes with risks. The value of your investment can go down as well as up, and you may not get back the full amount you invested.

CFD trading, on the other hand, allows you to speculate on the price movement of Bayer stock without actually owning any shares. This means that you don't have any rights as a shareholder, but it also means that your potential losses are limited to the size of your trade. CFD trading is a more flexible way to trade Bayer stock than investing, and it can be suited to shorter-term goals. However, it is important to remember that CFDs are leveraged products, which means that your losses can potentially exceed your initial investment.

Premium Standard

Swap long	[[ data.swapLong ]] points
Swap short	[[ data.swapShort ]] points
Spread min	[[ data.stats.minSpread ]]
Spread avg	[[ data.stats.avgSpread ]]
Min contract size	[[ data.minVolume ]]
Min step size	[[ data.stepVolume ]]
Commission and Swap	Commission and Swap
Leverage	Leverage
Trading Hours	Trading Hours

* The spreads provided are a reflection of the time-weighted average. Though Skilling attempts to provide competitive spreads during all trading hours, clients should note that these may vary and are susceptible to underlying market conditions. The above is provided for indicative purposes only. Clients are advised to check important news announcements on our Economic Calendar, which may result in the widening of spreads, amongst other instances.

The above spreads are applicable under normal trading conditions. Skilling has the right to amend the above spreads according to market conditions as per the 'Terms and Conditions'.

Trade Now

Trade [[data.name]] with Skilling

All Hassle-free, with flexible trade sizes and with zero commissions!*

Trade 24/5
Minimum margin requirements
No commission, only spread
Fractional shares available
Easy to use platform

*Other fees may apply.

FAQs

Which are the competitors of Bayer shares?

+ -

Bayer shares are traded on the Frankfurt Stock Exchange under the symbol BAYN. The company's primary competitors are BASF, Dow Chemical, and DuPont. Other companies in the chemical industry that compete with Bayer include Clariant, Evonik, Huntsman, and Lanxess. Bayer also competes with companies in the pharmaceutical and life sciences industries, such as Pfizer, Merck, and Novartis.

Who owns most Bayer shares?

+ -

The majority of Bayer shares are owned by institutional investors, with around 62% of the company's stock being held by investment firms, banks, and other financial institutions. The largest shareholder in Bayer is BlackRock, Inc., with a 6.4% stake in the company. Other major shareholders include Vanguard Group (5.7%), Capital World Investors (4.5%), and State Street Global Advisors (3.0%). Together, these four investors own around 19% of Bayer's shares.

Individual investors own the remaining 41% of Bayer's stock. The largest individual shareholder is Wolfgang Ullmann, who owns a 3.2% stake in the company. Other major individual shareholders include Klaus Kühn (2.7%), Rudolf von Bennigsen-Foerder (2.4%), and Hans-Jürgen Friedrich (1.9%). Together, these four investors own around 10% of Bayer's shares.

Do Bayer shares pay dividends?

+ -

Yes, Bayer shares pay dividends. The company has a long history of paying out dividends, and its dividend yield is currently around 4.3%. Bayer is a large, global company with a diversified business portfolio, so investors can expect a fairly stable dividend payments in the future. For example, Bayer paid out a total of €2 per share in dividends in 2020 and 2021. Bayer shareholders can thus expect to receive a relatively stable and growing stream of dividend income over time if the company continue to perform well.

Why Trade [[data.name]]

Make the most of price fluctuations - no matter what direction the price swings and without capital restrictions that come with buying the underlying asset.